Arndt Weinmann

12PUBLICATIONS
87CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersStochastic analysis and modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.

|Mar 28, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study.

Christian Möhring, Moritz Berger, Farsaneh Sadeghlar

|Nov 04, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.

Tiago de Castro, Sabrina Welland, Leonie Jochheim

|Oct 27, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.

Vincent Joerg, Bernhard Scheiner, Antonio D Alessio

|Sep 27, 2023
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.

Natascha Roehlen, Fabian Stoehr, Lukas Müller

|Feb 11, 2023
Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center.

Lea Penzkofer, Lisa-Katharina Gröger, Maria Hoppe-Lotichius

Pageof 2

Frequent Collaborators

4 joint publications

Roman Kloeckner

4 joint publications

Friedrich Foerster

3 joint publications

Bernhard Scheiner

3 joint publications

Ursula Ehmer